Abteilung für Urologie und Andrologie, Krankenhaus der Barmherzigen Brüder, Wien, Austria.
Despite the broad use of PSA-testing in western medicine, still an estimated 1/3 of carcinomas of the prostate (PC) are diagnosed in a locally advanced or metastatic stage. In the current treatment-algorithm for locally advanced PC, radical prostatectomy, external beam radiation therapy (with and without hormonal therapy) and primary androgendeprivation are available. In fact, in a majority of patients treatment of this tumor stage will be a multimodal approach, which has to be discussed individually. For metastatic PC hormonal deprivation therapy is still the gold standard. Beside LHRH-agonists, surgical castration and complete androgen deprivation today LHRH-antagonists represent the different therapeutic options in this tumor stage. Effects on natural course of this disease have to be balanced to the side effects of long-term therapy. Castration-resistant PC is not the object of this overview even though there are a variety of new medical interventions emerging for the treatment of this stage of PC.
Article in German.
Written by:
Ponholzer A, Steinbacher F, Madersbacher S, Schramek P. Are you the author?
Reference: Wien Med Wochenschr. 2011 Aug;161(15-16):377-81.
doi: 10.1007/s10354-011-0014-7
PubMed Abstract
PMID: 21953428
UroToday.com Prostate Cancer Section
